Anteilseigner
Sichuan Kelun Pharm (20,43 %) UBS Asset Management (Hong Kong) Ltd. (7,34 %) UBS SDIC Fund Management Co., Ltd. (2,06 %) The Vanguard Group, Inc. (1,83 %) Dimensional Fund Advisors LP (0,89 %) Norges Bank Investment Management (0,75 %) GF Fund Management Co., Ltd. (0,60 %) Penghua Fund Management Co., Ltd. (0,60 %) Fullgoal Fund Management Co., Ltd. (0,57 %) FIL Investment Management (Singapore) Ltd. (0,51 %) Nordea Investment Management AB (Denmark) (0,42 %) Bosera Asset Management Co., Ltd. (0,35 %) China Asset Management Co., Ltd. (0,20 %) Value Partners Ltd. (0,16 %) UBS Switzerland AG (Investment Management) (0,14 %) BlackRock Advisors (UK) Ltd. (0,13 %) Invesco Hong Kong Ltd. (0,12 %)
Kontakt
LIJUN INTERNATIONAL PHARMACEUTICAL